Drug Safety in Clinical Trials in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Drug Safety in Clinical Trials in Argentina

Drug Safety in Clinical Trials in Argentina – Cohortias the CRO of LATAM

Clinical trials are a vital component of medical research, facilitating the development of new treatments and advancing healthcare. Ensuring the safety of participants in these trials is of paramount importance. In Argentina, a robust regulatory framework is in place to safeguard participant well-being and maintain high ethical standards.

This blog post provides a comprehensive review of drug safety in clinical trials in Argentina, focusing on the regulatory landscape, ethical considerations, monitoring mechanisms, and collaborative efforts among stakeholders.

Regulatory Framework and Oversight

Argentina has a well-established regulatory framework for clinical trials, overseen by the National Administration of Drugs, Food and Medical Technology (ANMAT). ANMAT is responsible for reviewing and authorizing clinical trial protocols, ensuring compliance with ethical guidelines, and monitoring drug safety throughout the trial process.

To conduct a clinical trial in Argentina, researchers must obtain approval from ANMAT and receive ethical clearance from a local ethics committee (CEICA). The CEICA evaluates the scientific and ethical aspects of the trial, including participant selection criteria, informed consent procedures, and safety monitoring plans. This collaborative oversight between ANMAT and CEICAs ensures that clinical trials adhere to ethical principles and prioritize participant safety.

Ethical Considerations and Informed Consent

Ethical considerations are of paramount importance in the conduct of clinical trials in Argentina. The principles of autonomy, beneficence, and justice guide decision-making processes. Informed consent is a fundamental aspect of protecting participant rights and promoting drug safety.

In Argentina, obtaining informed consent is a mandatory requirement before enrolling participants in a clinical trial. Researchers are obliged to provide comprehensive information about the trial, including its purpose, procedures, potential risks, benefits, and alternatives.

This information must be presented in a clear and understandable manner, allowing participants sufficient time to ask questions and make an informed decision about their involvement.

Drug Safety in Clinical Trials in Argentina

Drug Safety in Clinical Trials in Argentina

Drug Safety in Clinical Trials in Argentina

Monitoring and Pharmacovigilance

Monitoring and pharmacovigilance are crucial components of drug safety in clinical trials in Argentina. ANMAT mandates that sponsors and researchers implement robust safety monitoring plans to promptly detect and manage adverse events or unexpected reactions during the trial.

Clinical trial sites in Argentina undergo regular inspections conducted by ANMAT and local health authorities. These inspections ensure compliance with the approved protocol, good clinical practices (GCP), and ethical guidelines. Monitoring activities help identify any deviations, ensuring trial integrity and participant safety.

Pharmacovigilance, the systematic monitoring and reporting of adverse events and other drug-related issues, is essential for maintaining drug safety. Researchers and sponsors are obligated to report all adverse events to ANMAT within specific timelines. ANMAT collaborates with national and international pharmacovigilance networks to assess the reported data and take appropriate actions to safeguard participant well-being.

Collaboration and Future Perspectives

Collaboration among stakeholders, including researchers, ethics committees, regulatory authorities, and sponsors, plays a vital role in ensuring drug safety in clinical trials. In Argentina, efforts to strengthen collaboration, promote transparency, and protect participant rights are ongoing.

Looking to the future, Argentina aims to enhance drug safety in clinical trials through the integration of advanced technologies. The adoption of electronic data capture, real-time monitoring systems, and data analytics can streamline safety reporting and facilitate early detection of potential risks.

Continued collaboration with international regulatory agencies and research networks can foster knowledge exchange and the harmonization of best practices, further elevating the standards of drug safety in Argentine clinical trials.


Argentina maintains a robust regulatory framework and ethical guidelines to ensure drug safety in clinical trials. The regulatory oversight provided by ANMAT, in conjunction with local ethics committees, ensures that clinical trials in Argentina adhere to rigorous standards and prioritize the safety and well-being of participants.

Drug Safety in Clinical Trials in Argentina

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Drug Safety in Clinical Trials in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Drug Safety in Clinical Trials in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Drug Safety in Clinical Trials in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Drug Safety in Clinical Trials in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Drug Safety in Clinical Trials in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Drug Safety in Clinical Trials in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Drug Safety in Clinical Trials in Argentina

The Cohortias Team

Drug Safety in Clinical Trials in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Drug Safety in Clinical Trials in Argentina

Network & Partnerships